Literature DB >> 20082532

An automatic occlusion device for remote control of tumor tissue ischemia.

Hamid El-Dahdah1, Bei Wang, Guanglong He, Ronald X Xu.   

Abstract

We developed an automatic occlusion device for remote control of tumor tissue ischemia. The device consists of a flexible cannula encasing a shape memory alloy wire with its distal end connected to surgical suture. Regional tissue occlusion was tested on both the benchtop and the animal models. In the benchtop test, the occlusion device introduced quantitative and reproducible changes of blood flow in a tissue simulating phantom embedding a vessel simulator. In the animal test, the device generated a cyclic pattern of reversible ischemia in the right hinder leg tissue of a black male C57BL/6 mouse. We also developed a multimodal detector that integrates near infrared spectroscopy and electron paramagnetic resonance spectroscopy for continuous monitoring of tumor tissue oxygenation, blood content, and oxygen tension changes. The multimodal detector was tested on a cancer xenograft nude mouse undergoing reversible tumor ischemia. The automatic occlusion device and the multimodal detector can be potentially integrated for closed-loop feedback control of tumor tissue ischemia. Such an integrated occlusion device may be used in multiple clinical applications such as regional hypoperfusion control in tumor resection surgeries and thermal ablation processes. In addition, the proposed occlusion device can also be used as a research tool to understand tumor oxygen transport and hemodynamic characteristics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082532      PMCID: PMC4332819          DOI: 10.1177/153303461000900108

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  30 in total

Review 1.  Oxygen transport-2. Tissue hypoxia.

Authors:  R M Leach; D F Treacher
Journal:  BMJ       Date:  1998-11-14

2.  Hemostatic laparoscopic partial nephrectomy: cable-tie compression.

Authors:  J A Cadeddu; T S Corwin; O Traxer; C Collick; H H Saboorian; M S Pearle
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

Review 3.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

Authors:  R A Kloner; R B Jennings
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

4.  Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study.

Authors:  Britton Chance; Shoko Nioka; Jun Zhang; Emily F Conant; Emily Hwang; Susanne Briest; Susan G Orel; Mitchell D Schnall; Brian J Czerniecki
Journal:  Acad Radiol       Date:  2005-08       Impact factor: 3.173

5.  Significance of blood vessel leakiness in cancer.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

6.  Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer.

Authors:  P J Le Pivert; D R Morrison; R S Haddad; M Renard; A Aller; K Titus; J Doulat
Journal:  Technol Cancer Res Treat       Date:  2009-06

7.  An automated coronary artery occlusion device for stimulating collateral development in vivo.

Authors:  Richard Rys; John F LaDisa; John P Tessmer; Weidong Gu; Judy R Kersten; David C Warltier; Paul S Pagel
Journal:  J Pharmacol Toxicol Methods       Date:  2002 Sep-Oct       Impact factor: 1.950

8.  Oxygen distributions within R3230Ac tumors growing in dorsal flap window chambers in rats.

Authors:  D F Wilson; S M Evans; W T Jenkins; S A Vinogradov; E Ong; M W Dewhirst
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

9.  MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions.

Authors:  Vasilis Ntziachristos; A G Yodh; Mitchell D Schnall; Britton Chance
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

10.  Renal hypothermia: in vivo and ex vivo.

Authors:  A C Novick
Journal:  Urol Clin North Am       Date:  1983-11       Impact factor: 2.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.